Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PG 760564 in adults with rheumatoid arthritis receiving methotrexate
2006-002216-10Phase 2Completed
- Sponsor
- Procter & Gamble
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of PG-760564 in rheumatoid arthritis (RA) (3 arms), sponsored by Procter & Gamble. Primary endpoint: ACR20 response at 12 weeks. Started Oct 2006; status: completed.
02
Drugs
PG-760564
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2006-002216-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002216-10.